Huaxuan Li

650 total citations · 1 hit paper
13 papers, 457 citations indexed

About

Huaxuan Li is a scholar working on Molecular Biology, Oncology and Animal Science and Zoology. According to data from OpenAlex, Huaxuan Li has authored 13 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Animal Science and Zoology. Recurrent topics in Huaxuan Li's work include Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (2 papers). Huaxuan Li is often cited by papers focused on Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (2 papers). Huaxuan Li collaborates with scholars based in China, United States and Macao. Huaxuan Li's co-authors include Yuanxiang Wang, Shumin Ouyang, Xiaolei Zhang, Wen Ding, Peiqing Liu, Jiaye Lu, Ziyou Lin, Peibin Yue, Linlin Lou and Junjian Wang and has published in prestigious journals such as Journal of Medicinal Chemistry, Cancer Letters and International Journal of Biological Macromolecules.

In The Last Decade

Huaxuan Li

12 papers receiving 453 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer

2022 323 citations Shumin Ouyang, Huaxuan Li et al. Redox Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huaxuan Li China	7	265	209	167	99	63	13	457
Linlin Lou China	7	297 1.1×	212 1.0×	170 1.0×	104 1.1×	66 1.0×	10	483
Yunhong Zhan China	10	280 1.1×	152 0.7×	153 0.9×	130 1.3×	47 0.7×	14	450
Yeung Ho United States	12	253 1.0×	248 1.2×	176 1.1×	123 1.2×	37 0.6×	13	537
Yang-ling Li China	11	229 0.9×	77 0.4×	102 0.6×	82 0.8×	27 0.4×	22	350
Piyada Sitthideatphaiboon Thailand	8	232 0.9×	116 0.6×	128 0.8×	129 1.3×	30 0.5×	24	379
Grace L. Wong United States	9	341 1.3×	77 0.4×	150 0.9×	229 2.3×	82 1.3×	13	578
Lin‐wen Wu China	12	225 0.8×	69 0.3×	82 0.5×	88 0.9×	35 0.6×	18	381
Anja Schmall Germany	5	206 0.8×	114 0.5×	74 0.4×	152 1.5×	177 2.8×	7	453
Xinzhou Deng China	13	298 1.1×	72 0.3×	135 0.8×	136 1.4×	137 2.2×	26	470
Renle Du China	13	231 0.9×	53 0.3×	109 0.7×	140 1.4×	107 1.7×	24	429

Countries citing papers authored by Huaxuan Li

Since Specialization

Citations

This map shows the geographic impact of Huaxuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaxuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaxuan Li more than expected).

Fields of papers citing papers by Huaxuan Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaxuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaxuan Li. The network helps show where Huaxuan Li may publish in the future.

Co-authorship network of co-authors of Huaxuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Huaxuan Li. A scholar is included among the top collaborators of Huaxuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaxuan Li. Huaxuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pan, Yuanhu, Guohui Sun, Li Guo, et al.. (2025). Sex-specific microbiota associations with backfat thickness, eye muscle area, and rumen fermentation in Qinchuan cattle. BMC Microbiology. 25(1). 277–277.

Li, Huaxuan, et al.. (2024). SERPINE1AS2 regulates intramuscular adipogenesis by inhibiting PAI1 protein expression. International Journal of Biological Macromolecules. 275(Pt 2). 133592–133592. 2 indexed citations

Pan, Yuanhu, Huaxuan Li, Xiaolei Sun, et al.. (2024). Gender and age-related variations in rumen fermentation and microbiota of Qinchuan cattle. Animal Bioscience. 38(5). 941–954. 1 indexed citations

Li, Huaxuan, Hong Yang, Li Liu, et al.. (2024). One stone two birds: Introducing piperazine into a series of nucleoside derivatives as potent and selective PRMT5 inhibitors. European Journal of Medicinal Chemistry. 281. 116970–116970. 1 indexed citations

Li, Bang, Huaxuan Li, Hong Yang, et al.. (2024). Discovery of a Highly Potent Lysine Methyltransferases G9a/NSD2 Dual Inhibitor to Treat Solid Tumors. Journal of Medicinal Chemistry. 67(18). 16072–16087. 6 indexed citations

Wang, Jianfang, et al.. (2024). Identification of key genes and metabolites involved in meat quality performance in Qinchuan cattle by WGCNA. Journal of Integrative Agriculture. 23(11). 3923–3937. 5 indexed citations

Zhang, Yi, Huaxuan Li, Junhua Wang, et al.. (2023). Structure-Based Design and Characterization of the Highly Potent and Selective Covalent Inhibitors Targeting the Lysine Methyltransferases G9a/GLP. Journal of Medicinal Chemistry. 66(12). 8086–8102. 16 indexed citations

Lu, Jiaye, Jingwei Li, Ziyou Lin, et al.. (2023). Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer. Cancer Letters. 564. 216205–216205. 57 indexed citations

Zhang, Yi, Hong Yang, Bingbing Li, et al.. (2023). Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2. Journal of Medicinal Chemistry. 66(11). 7629–7644. 13 indexed citations

10.

Li, Huaxuan, Shumin Ouyang, Yi Zhang, et al.. (2022). Structural optimization of Imidazo[1, 2-a]pyridine derivatives for the treatment of gastric cancer via STAT3 signaling pathway. European Journal of Medicinal Chemistry. 244. 114858–114858. 6 indexed citations

11.

Deng, Linhong, Jianshan Mo, Yi Zhang, et al.. (2022). Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3. Journal of Medicinal Chemistry. 65(19). 13094–13111. 9 indexed citations

12.

Ouyang, Shumin, Huaxuan Li, Linlin Lou, et al.. (2022). Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biology. 52. 102317–102317. 323 indexed citations breakdown →

13.

Li, Haoran, Huaxuan Li, Pingyuan Wang, et al.. (2022). Discovery of Marine Natural Products as Promising Antibiotics against Pseudomonas aeruginosa. Marine Drugs. 20(3). 192–192. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact